Eric

Well, because I've slept like shit forever. So that's my hunch there.

Well, because I've slept like shit forever. So that's my hunch there.

I'm just pointing out you have an argument for one thing that you feel solid about, which was GLP-1's work for diabetics. It wasn't being studied for obesity. It is very safe. And now it turns out it's great for obesity. So we are at a phase with many peptides where the off-label use is just now happening. And it's already been studied for these other things to be safe.

I'm just pointing out you have an argument for one thing that you feel solid about, which was GLP-1's work for diabetics. It wasn't being studied for obesity. It is very safe. And now it turns out it's great for obesity. So we are at a phase with many peptides where the off-label use is just now happening. And it's already been studied for these other things to be safe.

I'm just pointing out you have an argument for one thing that you feel solid about, which was GLP-1's work for diabetics. It wasn't being studied for obesity. It is very safe. And now it turns out it's great for obesity. So we are at a phase with many peptides where the off-label use is just now happening. And it's already been studied for these other things to be safe.

So now we're just at the point where we're going to evaluate them for the off-label use. use, but you guys are going, no, don't use it for off-label because we don't have that study yet. It's a little contradictory to your embracing of the GLP-1s.

So now we're just at the point where we're going to evaluate them for the off-label use. use, but you guys are going, no, don't use it for off-label because we don't have that study yet. It's a little contradictory to your embracing of the GLP-1s.

So now we're just at the point where we're going to evaluate them for the off-label use. use, but you guys are going, no, don't use it for off-label because we don't have that study yet. It's a little contradictory to your embracing of the GLP-1s.

So where the data is totally fine. Yeah. But a pessimism about that the data will prove out to be not real, I don't think is warranted. I think it should be given the same neutral opinion that the GLP ones.

So where the data is totally fine. Yeah. But a pessimism about that the data will prove out to be not real, I don't think is warranted. I think it should be given the same neutral opinion that the GLP ones.

So where the data is totally fine. Yeah. But a pessimism about that the data will prove out to be not real, I don't think is warranted. I think it should be given the same neutral opinion that the GLP ones.

I agree. That's a huge problem.

I agree. That's a huge problem.

I agree. That's a huge problem.

It's like, I hate that the government regulates. Okay, well, now it's been stolen from you. And what do you want now? You want a regulatory committee to come in and chase down your money and give it back. So everything you liked about it, you now are a victim of. And now you want all the regulation.

It's like, I hate that the government regulates. Okay, well, now it's been stolen from you. And what do you want now? You want a regulatory committee to come in and chase down your money and give it back. So everything you liked about it, you now are a victim of. And now you want all the regulation.

It's like, I hate that the government regulates. Okay, well, now it's been stolen from you. And what do you want now? You want a regulatory committee to come in and chase down your money and give it back. So everything you liked about it, you now are a victim of. And now you want all the regulation.

I totally agree with that mindset of I just want anything that's not that thing I hate is ridiculous and dangerous.

I totally agree with that mindset of I just want anything that's not that thing I hate is ridiculous and dangerous.

I totally agree with that mindset of I just want anything that's not that thing I hate is ridiculous and dangerous.